TRZ-2
Dual GIP / GLP-1 Agonist · CAS 2023788-19-2
Add $70.05 to unlock 7.5% off.
Free shipping over $225
About TRZ-2.
Tirzepatide is a dual agonist that engages both the GIP and GLP-1 receptors. By acting on two metabolic receptor pathways at once, it has become a notable compound in laboratory research on energy and glucose handling. Research interest in Tirzepatide centers on glucose metabolism, appetite regulation, and broader metabolic signaling. It is provided as a 30mg lyophilized powder per vial for experimental use. Supplied for research, laboratory, and analytical purposes only. Human or animal consumption is prohibited.
All material supplied for research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
- ◆1 × sealed vial — 30mg lyophilized TRZ-2
- ◆Tamper-evident pharma-grade packaging
- ◆Batch-specific COA (also available online)
The full sheet.
- CAS Number
- CAS 2023788-19-2
- Molecular formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Molecular weight
- 4813.45 g/mol
- Form
- Lyophilized powder
- Category
- Metabolic
- Net weight
- 30mg
- Reconstitution
- Bacteriostatic water (0.9% benzyl alcohol)
- Storage
- Lyophilized: −20°C, sealed & protected from light. Reconstituted: 2–8°C, use within 30 days.
Every batch verified.
Third-party HPLC and mass spectrometry on every lot. The full COA for this batch is below, with peak chromatogram and signed lab report.
